Qube Research & Technologies (QRT)
PDLI

Qube Research & Technologies (QRT)’s PDL BioPharma, Inc. PDLI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,360
Closed -$115K – 2379
2020
Q3 		$115K Buy
+36,360
New +$116K ﹤0.01% 1482
2020
Q1 		– Sell
-14,457
Closed -$47K – 1927
2019
Q4 		$47K Buy
+14,457
New +$42K ﹤0.01% 1483

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PDLI Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 36,360 shares — an estimated $115K sold.

Qube Research & Technologies (QRT) first reported a position in PDLI in Q4 2019 and held it in 2 quarters. The position peaked at $115K in Q3 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 36,360 PDL BioPharma, Inc. shares in Q4 2020, an estimated $115K.
  • Qube Research & Technologies (QRT) first reported a position in PDL BioPharma, Inc. in Q4 2019 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s PDL BioPharma, Inc. position peaked at $115K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.